Eradication of Malignant Carcinoma in the Breast Tissue
Phase 2
Completed
- Conditions
- Breast Cancer
- Registration Number
- NCT02286778
- Lead Sponsor
- Optimal Health Research
- Brief Summary
The purpose of this study is to confirm the findings of an early study and expand our knowledge of treating Malignant Carcinoma in the Breast Tissue Using an ATP (Adenosine-5'-Triphosphate) Inhibitor.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
- Clinical diagnosis of breast cancer
- Referred to the study by their treating physician
Exclusion Criteria
- Any type of treatment for breast cancer before starting the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Number of participants tumor free 12 months assessed by MRI
- Secondary Outcome Measures
Name Time Method